» Articles » PMID: 31318600

Ongoing Disparities in Prediagnosis Preexposure Prophylaxis Use Among Persons Recently Diagnosed With HIV in New York City, 2015-2017

Overview
Specialty Public Health
Date 2019 Jul 19
PMID 31318600
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

To quantify sociodemographic disparities in prediagnosis preexposure prophylaxis (PrEP) use in persons recently diagnosed with HIV in New York City and assigned for partner services. We used partner services data from November 2015 to September 2017 from persons diagnosed with HIV in the past 12 months (n = 3739) to compare individuals with self-reported or documented pre-HIV diagnosis PrEP use ("prediagnosis PrEP users") with those having none ("never users"). We constructed a penalized likelihood regression model generating sociodemographic predictors of prediagnosis PrEP use, employing Firth's adjustment for the rare outcome. We found report of prediagnosis PrEP use in 95 persons (3%). The adjusted odds ratios (AORs) of prediagnosis PrEP use were lower among non-Hispanic Blacks (AOR = 0.18; 95% confidence interval [CI] = 0.09, 0.32) and Hispanics (AOR = 0.31; 95% CI = 0.17, 0.55) than among non-Hispanic Whites, among persons aged 30 years or older (AOR = 0.45; 95% CI = 0.28, 0.72) than those younger than 30 years, among cis-women (AOR = 0.13; 95% CI = 0.02, 0.48) than cis-men, and among residents of Queens (AOR = 0.25; 95% CI = 0.10, 0.55) than those of Manhattan. Disparities in HIV prevention based on race/ethnicity, gender, age, and local geography may manifest themselves in differential PrEP use.

Citing Articles

Examining HIV Diagnosis and Linkage to PrEP Prescription Among Members at An Integrated Health System in the Southeast United States.

Davis T, Mittal M, Oragwu A, Wang M, Boekeloo B AIDS Behav. 2022; 27(3):796-805.

PMID: 36097086 DOI: 10.1007/s10461-022-03812-4.


Pre-Exposure Prophylaxis (PrEP) Dissemination: Adapting Diffusion Theory to Examine PrEP Adoption.

Schuyler A, Alidina Z, Dolcini M, Harper G, Fortenberry J, Singh R AIDS Behav. 2021; 25(10):3145-3158.

PMID: 34152531 PMC: 11298242. DOI: 10.1007/s10461-021-03345-2.


Multilevel Factors Shaping Awareness of and Attitudes Toward Pre-exposure Prophylaxis for HIV Prevention among Criminal Justice-Involved Women.

Dauria E, Levine A, Hill S, Tolou-Shams M, Christopoulos K Arch Sex Behav. 2020; 50(4):1743-1754.

PMID: 33236275 PMC: 8276158. DOI: 10.1007/s10508-020-01834-4.


Misinformation, Gendered Perceptions, and Low Healthcare Provider Communication Around HPV and the HPV Vaccine Among Young Sexual Minority Men in New York City: The P18 Cohort Study.

Jaiswal J, LoSchiavo C, Maiolatesi A, Kapadia F, Halkitis P J Community Health. 2020; 45(4):702-711.

PMID: 32016677 PMC: 7774381. DOI: 10.1007/s10900-019-00784-w.

References
1.
Bocour A, Renaud T, Wong M, Udeagu C, Shepard C . Differences in risk behaviors and partnership patterns between younger and older men who have sex with men in New York City. J Acquir Immune Defic Syndr. 2011; 58(4):417-23. DOI: 10.1097/QAI.0b013e318230e6d9. View

2.
Calabrese S, Krakower D, Mayer K . Integrating HIV Preexposure Prophylaxis (PrEP) Into Routine Preventive Health Care to Avoid Exacerbating Disparities. Am J Public Health. 2017; 107(12):1883-1889. PMC: 5678380. DOI: 10.2105/AJPH.2017.304061. View

3.
Sullivan P, Rosenberg E, Sanchez T, Kelley C, Luisi N, Cooper H . Explaining racial disparities in HIV incidence in black and white men who have sex with men in Atlanta, GA: a prospective observational cohort study. Ann Epidemiol. 2015; 25(6):445-54. PMC: 4433604. DOI: 10.1016/j.annepidem.2015.03.006. View

4.
Collier K, Colarossi L, Sanders K . Raising Awareness of Pre-Exposure Prophylaxis (PrEP) among Women in New York City: Community and Provider Perspectives. J Health Commun. 2017; 22(3):183-189. DOI: 10.1080/10810730.2016.1261969. View

5.
Aaron E, Blum C, Seidman D, Hoyt M, Simone J, Sullivan M . Optimizing Delivery of HIV Preexposure Prophylaxis for Women in the United States. AIDS Patient Care STDS. 2018; 32(1):16-23. PMC: 5756936. DOI: 10.1089/apc.2017.0201. View